Literature DB >> 21681934

Constitutional tandem duplication of 9q34 that truncates EHMT1 in a child with ganglioglioma.

Hannah C Cheung1, Svetlana A Yatsenko, Meena Kadapakkam, Hélène Legay, Jack Su, James R Lupski, Sharon E Plon.   

Abstract

Point mutations of EHMT1 or deletions and duplications of chromosome 9q34.3 are found in patients with variable neurologic and developmental disorders. Here, we present a child with congenital cataract, developmental and speech delay who developed a metastatic ganglioglioma with progression to anaplastic astrocytoma. Molecular analysis identified a novel constitutional tandem duplication in 9q34.3 with breakpoints in intron 1 of TRAF2 and intron 16 of EHMT1 generating a fusion transcript predicted to encode a truncated form of EHMT1. The ganglioglioma showed complex chromosomal aberrations with further duplication of the dup9q34. Thus, this unique tandem 9q34.3 duplication may impact brain tumor formation.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681934      PMCID: PMC3202030          DOI: 10.1002/pbc.23219

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  19 in total

1.  A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells.

Authors:  Hidesato Ogawa; Kei-Ichiro Ishiguro; Stefan Gaubatz; David M Livingston; Yoshihiro Nakatani
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

2.  Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome.

Authors:  Svetlana A Yatsenko; Ellen K Brundage; Erin K Roney; Sau Wai Cheung; A Craig Chinault; James R Lupski
Journal:  Hum Mol Genet       Date:  2009-03-17       Impact factor: 6.150

3.  G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription.

Authors:  Makoto Tachibana; Yasuko Matsumura; Mikiko Fukuda; Hiroshi Kimura; Yoichi Shinkai
Journal:  EMBO J       Date:  2008-09-25       Impact factor: 11.598

Review 4.  Chromosome imbalances in familial gliomas detected by comparative genomic hybridization.

Authors:  N Paunu; S L Sallinen; R Karhu; H Miettinen; P Sallinen; J Kononen; P Laippala; K O Simola; P Helén; H Haapasalo
Journal:  Genes Chromosomes Cancer       Date:  2000-12       Impact factor: 5.006

5.  Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma.

Authors:  Paul A Northcott; Yukiko Nakahara; Xiaochong Wu; Lars Feuk; David W Ellison; Sid Croul; Stephen Mack; Paul N Kongkham; John Peacock; Adrian Dubuc; Young-Shin Ra; Karen Zilberberg; Jessica McLeod; Stephen W Scherer; J Sunil Rao; Charles G Eberhart; Wiesia Grajkowska; Yancey Gillespie; Boleslaw Lach; Richard Grundy; Ian F Pollack; Ronald L Hamilton; Timothy Van Meter; Carlos G Carlotti; Frederick Boop; Darrell Bigner; Richard J Gilbertson; James T Rutka; Michael D Taylor
Journal:  Nat Genet       Date:  2009-03-08       Impact factor: 38.330

6.  Distinct roles for histone methyltransferases G9a and GLP in cancer germ-line antigen gene regulation in human cancer cells and murine embryonic stem cells.

Authors:  Petra A Link; Omkaram Gangisetty; Smitha R James; Anna Woloszynska-Read; Makoto Tachibana; Yoichi Shinkai; Adam R Karpf
Journal:  Mol Cancer Res       Date:  2009-06-16       Impact factor: 5.852

7.  Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.

Authors:  T Kleefstra; W A van Zelst-Stams; W M Nillesen; V Cormier-Daire; G Houge; N Foulds; M van Dooren; M H Willemsen; R Pfundt; A Turner; M Wilson; J McGaughran; A Rauch; M Zenker; M P Adam; M Innes; C Davies; A González-Meneses López; R Casalone; A Weber; L A Brueton; A Delicado Navarro; M Palomares Bralo; H Venselaar; S P A Stegmann; H G Yntema; H van Bokhoven; H G Brunner
Journal:  J Med Genet       Date:  2009-03-04       Impact factor: 6.318

8.  ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.

Authors:  Shuhei Matsuoka; Bryan A Ballif; Agata Smogorzewska; E Robert McDonald; Kristen E Hurov; Ji Luo; Corey E Bakalarski; Zhenming Zhao; Nicole Solimini; Yaniv Lerenthal; Yosef Shiloh; Steven P Gygi; Stephen J Elledge
Journal:  Science       Date:  2007-05-25       Impact factor: 47.728

9.  Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells.

Authors:  Yutaka Kondo; Lanlan Shen; Saira Ahmed; Yanis Boumber; Yoshitaka Sekido; Bassem R Haddad; Jean-Pierre J Issa
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

10.  Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.

Authors:  David T W Jones; Sylvia Kocialkowski; Lu Liu; Danita M Pearson; L Magnus Bäcklund; Koichi Ichimura; V Peter Collins
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

View more
  4 in total

Review 1.  Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease.

Authors:  Jill S Butler; Evangelia Koutelou; Andria C Schibler; Sharon Y R Dent
Journal:  Epigenomics       Date:  2012-04       Impact factor: 4.778

2.  Human subtelomeric copy number gains suggest a DNA replication mechanism for formation: beyond breakage-fusion-bridge for telomere stabilization.

Authors:  Svetlana A Yatsenko; Patricia Hixson; Erin K Roney; Daryl A Scott; Christian P Schaaf; Yu-tze Ng; Robbin Palmer; Richard B Fisher; Ankita Patel; Sau Wai Cheung; James R Lupski
Journal:  Hum Genet       Date:  2012-08-14       Impact factor: 4.132

3.  Chimeric Genes in Deletions and Duplications Associated with Intellectual Disability.

Authors:  Sonia Mayo; Sandra Monfort; Mónica Roselló; Carmen Orellana; Silvestre Oltra; Alfonso Caro-Llopis; Francisco Martínez
Journal:  Int J Genomics       Date:  2017-05-24       Impact factor: 2.326

Review 4.  Potential Epigenetic-Based Therapeutic Targets for Glioma.

Authors:  Lanlan Zang; Shukkoor Muhammed Kondengaden; Fengyuan Che; Lijuan Wang; Xueyuan Heng
Journal:  Front Mol Neurosci       Date:  2018-11-15       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.